CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION is a premier academic journal published by Lippincott Williams & Wilkins, focusing on the latest advancements and research in the fields of nephrology and hypertension. Since its inception in 1992, this journal has been an essential resource for professionals seeking to stay at the forefront of kidney health and blood pressure management. With a distinguished ranking in the top quartile (Q1) for both Internal Medicine and Nephrology as of 2023, the journal is recognized for its high impact, currently holding a Scopus rank of #16 out of 81 in Nephrology, positioning it in the 80th percentile. Although not an open access journal, it provides crucial insights and expert opinions that cater to researchers, clinicians, and students committed to improving patient outcomes through evidence-based practice. The journal continues to emphasize its objectives of disseminating pivotal findings and fostering discussions that bridge the gap between clinical practice and research, making it an invaluable asset in the evolving landscape of nephrology and hypertension.

NEPHROLOGY is a leading academic journal published by Wiley, dedicated to advancing research and discussions in the fields of Nephrology and Medicine. With an ISSN of 1320-5358, this journal has consistently demonstrated its significance and impact, reflecting a Q2 category ranking in both Medicine (miscellaneous) and Nephrology as of 2023. Covering a comprehensive range of topics since its inception in 1995, NEPHROLOGY provides a vital platform for researchers, practitioners, and students alike to explore the latest advancements, innovative treatments, and diverse challenges within the field. Although it does not operate under an open access model, the journal remains highly regarded, with a commendable Scopus rank of #27 out of 81 in Nephrology, positioning it in the 67th percentile among its peers. Located in the United Kingdom, NEPHROLOGY invites submissions that push the boundaries of knowledge, ultimately striving to enhance the understanding of renal health and disease.

Kidney International Reports, published by ELSEVIER SCIENCE INC, stands as a premier open-access journal in the realm of nephrology, having established itself since its inception in 2016. This scholarly platform, with an ISSN of 2468-0249, is dedicated to presenting high-quality research and critical reviews that advance our understanding of kidney health and disease. With a remarkable Q1 ranking in nephrology and a notable position within the top 10 of Scopus rankings for this specialty, the journal is a pivotal resource for researchers, healthcare professionals, and students alike. Featuring a broad scope of topics from clinical nephrology to innovative treatment strategies, Kidney International Reports ensures accessibility to the latest findings through its open access model, making it instrumental in promoting knowledge sharing and collaboration across the global nephrology community. The journal's commitment to excellence not only enhances the visibility of research but also fosters the development of effective treatments and therapies for kidney diseases.

NEPHRON is a premier peer-reviewed academic journal dedicated to advancing the field of nephrology and renal medicine. Published by KARGER, renowned for its commitment to quality research, NEPHRON serves as a vital resource for researchers, clinicians, and students interested in the latest findings and developments in kidney health. With an ISSN of 1660-8151 and an E-ISSN of 2235-3186, the journal ensures wide accessibility and dissemination of knowledge in the renal domain. Although specific impact metrics such as the HIndex are presently unavailable, NEPHRON's emphasis on Open Access publishing greatly enhances its visibility and accessibility, allowing groundbreaking research to reach a global audience. Through a comprehensive scope that encompasses clinical studies, basic research, and translational science, NEPHRON contributes significantly to the understanding and treatment of kidney diseases. Join the vibrant community of professionals and scholars who are shaping the future of nephrology by engaging with the wealth of knowledge presented in NEPHRON.

NEFROLOGIA is a preeminent scientific journal published by the SOCIEDAD ESPAÑOLA DE NEFROLOGÍA DR. RAFAEL MATESANZ, specializing in cutting-edge research and clinical advancements in the field of nephrology. Established in 1981 and continuing through 2024, this journal serves as a crucial platform for nephrologists, researchers, and healthcare professionals to disseminate knowledge and foster dialogue on critical issues affecting kidney health. With its ISSN 0211-6995 and E-ISSN 1989-2284, NEFROLOGIA is indexed in prestigious databases, ranking #35 out of 81 in the Scopus Medicine Nephrology category, reflecting its significance within the medical community. Although it does not currently offer open access, the journal ensures wide accessibility and readership through institutional subscriptions. Researchers and clinicians are invited to contribute their findings and reviews, advancing our understanding and treatment of renal diseases. Through its commitment to high scholarly standards and impactful research, NEFROLOGIA remains a vital resource for those dedicated to improving kidney care and advancing nephrology sciences.

Nature Reviews Nephrology is a prestigious academic journal published by NATURE PORTFOLIO, focusing on the rapidly evolving field of nephrology. As a leader in its category, it holds an impressive Q1 ranking in the 2023 category for Nephrology and ranks #1 out of 81 in the Scopus metrics, reflecting its high impact and relevance within the scientific community, with a staggering 99th percentile ranking. Established in 2009, this journal provides in-depth reviews, critical analysis, and cutting-edge research updates, making it an essential resource for researchers, professionals, and students alike. With an accessible Open Access policy, it enhances the dissemination of knowledge, ensuring that vital research in renal health and disease reaches a wide audience. Situated in the United Kingdom, Nature Reviews Nephrology remains committed to advancing understanding and treatment in nephrology, emphasizing the importance of this area of study in improving patient outcomes globally.

Nephrologie, published by Springer Heidelberg, is a vital addition to the field of nephrology, providing a dedicated platform for the dissemination of cutting-edge research and clinical practices in kidney health. With its ISSN 2731-7463 and E-ISSN 2731-7471, this journal facilitates open access to a range of articles aimed at enhancing understanding and treatment of renal disorders. Located in Germany, Nephrologie is recognized for its commitment to advancing nephrological knowledge despite being currently categorized in the Q4 quartile and holding a Scopus rank of #80/81 within its field, indicating its emerging potential in the academic landscape. Operating from Tiergartenstraße 17, D-69121 Heidelberg, Germany, the journal encompasses a diverse scope that includes original research, review articles, and clinical studies, fostering a collaborative environment among researchers, healthcare professionals, and students. As it converges between 2022 and 2024, Nephrologie positions itself as a crucial resource for those committed to improving renal patient care and outcomes.

Kidney & Blood Pressure Research, published by KARGER, is a premier open-access journal dedicated to the evolving fields of nephrology and cardiovascular medicine. Since its inception in 1978 and with a forward-looking scope extending to 2024, this journal plays a vital role in disseminating innovative research and clinical findings related to kidney health and blood pressure regulation. With an impressive 2023 Impact Factor and ranked in the second quartile (Q2) in both cardiology and nephrology categories, it is recognized as a significant resource among its peers, including a Scopus rank of #23 in Nephrology and #128 in Cardiology. The journal's commitment to open access since 2013 further ensures that cutting-edge research is readily available to the global scientific community. Based in Switzerland, the journal not only fosters academic collaboration but also addresses critical health challenges related to kidney function and hypertension. It is a crucial platform for researchers, healthcare professionals, and students alike, encouraging the ongoing dialogue and advancement of knowledge in these critical areas of health.

The American Journal of Kidney Diseases, published by W B Saunders Co-Elsevier Inc, stands as a premier academic resource in the field of nephrology, with an impressive impact factor that highlights its significance in advancing kidney health research. Since its inception in 1981, this journal has consistently provided a platform for innovative studies and critical reviews that shape clinical practices and policies in kidney disease management, achieving a prestigious Q1 ranking within the nephrology category as of 2023. With an H-index reflective of its research dynamism and influence, the journal has become an essential read for professionals, researchers, and students keen on the latest scientific advancements. While the journal does not offer Open Access, it continues to maintain high standards for the quality and relevance of its published content, making it indispensable for those dedicated to understanding and combating kidney diseases. Its address is located in Philadelphia, PA, further solidifying its commitment to fostering knowledge in the United States and beyond.

CLINICAL NEPHROLOGY is a prestigious academic journal dedicated to advancing the field of nephrology and related areas of medicine. Published by DUSTRI-VERLAG DR KARL FEISTLE, this journal has been a critical resource for researchers and practitioners since its inception in 1973, with a commitment to disseminating high-quality, peer-reviewed articles that provide insights into clinical practices, innovative treatments, and emerging research in kidney diseases. With an ISSN of 0301-0430, CLINICAL NEPHROLOGY stands out in the medical community, achieving a commendable Q3 ranking in both general medicine and nephrology fields as of 2023. The journal's focus on both clinical application and rigorous scientific inquiry makes it an essential read for healthcare professionals and researchers looking to stay at the forefront of nephrology advancements. Although it operates under a subscription model, its broad scope promises invaluable contributions that address practical challenges and foster interdisciplinary dialogue within the healthcare landscape.